| 注册
首页|期刊导航|哈尔滨医药|血小板抗体、交叉配型与骨髓瘤输注无效相关性研究

血小板抗体、交叉配型与骨髓瘤输注无效相关性研究

苏情 傅丽霞 巢玲

哈尔滨医药2025,Vol.45Issue(2):37-39,3.
哈尔滨医药2025,Vol.45Issue(2):37-39,3.DOI:10.3969/j.issn.1001-8131.2025.02.011

血小板抗体、交叉配型与骨髓瘤输注无效相关性研究

Study on the Correlation between Platelet Antibodies Cross Matching and Ineffectiveness of Myeloma Infusion

苏情 1傅丽霞 2巢玲1

作者信息

  • 1. 宜春市人民医院,江西 宜春 336000
  • 2. 新余市人民医院,江西 新余 338000
  • 折叠

摘要

Abstract

Objective To explore the correlation between platelet antibodies,cross matching results,and ineffective platelet transfusion in patients with multiple myeloma.Method A retrospective analysis was conducted on 124 patients with multiple myeloma.The patients were divided into an effective group and an ineffective group based on whether platelet transfusion was effective.Among them,there were 100 cases in the effective group and 24 cases in the ineffective group.Compare the clinical data,platelet antibodies,and cross matching results of two groups of patients,and analyze the correlation between platelet antibodies,cross matching results,and ineffective platelet transfusion in patients with multiple myeloma,as well as the influencing factors of ineffective platelet transfusion.Result Factor analysis showed that splenomegaly(β=3.524,...),OR=3.933,95%Cl=7.047-13.397)、Heat generation(β=1.630,OR=5.102,95%Cl=1.389-18.744)、Platelet antibody positivity(β=2.114,OR=8.280,95%Cl=2.056-23.340)and cross matching positivity(β=1.548,OR=4.701,95%Cl=1.104-20.016)are both influencing factors for ineffective platelet transfusion in patients.Conclusion Positive platelet antibodies,cross matching,fever,and splenomegaly are independent influencing factors for ineffective platelet transfusion in patients with multiple myeloma.Clinical attention should be paid to patients with multiple myeloma who are accompanied by these influencing factors.

关键词

血小板抗体/交叉配型/多发性骨髓瘤/血小板输注

Key words

platelet antibodies/Cross matching/Multiple myeloma/Platelet infusion

分类

医药卫生

引用本文复制引用

苏情,傅丽霞,巢玲..血小板抗体、交叉配型与骨髓瘤输注无效相关性研究[J].哈尔滨医药,2025,45(2):37-39,3.

哈尔滨医药

1001-8131

访问量5
|
下载量0
段落导航相关论文